Toelichting op glucosamine
Glucosamine (wetenschappelijke naam: 2-Amino-2-deoxyglucose)
Kraakbeen bestaat uit collageen, elastine en een matrix van lange suiker-eiwitmolecules genaamd proteoglycanen en glycosaminoglycanen. Deze glycosaminoglycanen zijn uitermate belangrijk voor het vermogen van kraakbeen te fungeren als een schokdemper; door hun sterke waterabsorptie maken ze kraakbeen gelachtig en veerkrachtig. Artrose wordt gekenmerkt door een progressieve degeneratie van de kraakbeenglycosaminoglycanen. Glucosamine vergemakkelijkt de synthese van glycosaminoglycanen; het aanvullen van de beschikbaarheid van glucosamine vertraagt daarom de degeneratie van het kraakbeen. Glucosamine kan ook ontstekingen verminderen en kraakbeen beschermen tegen schade veroorzaakt door NSAID's, corticosteroïden.
€ 18,90
incl. BTW
Gratis verzending naar de volgende landen: België, Duitsland, Frankrijk, Nederland Meer tonen Laat minder zien
1. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000;283:1469-75.
2. Nguyen P, Mohamed SE, Gardiner D, Salinas T. A randomized double-blind clinical trial of the effect of chondroitin sulfate and glucosamine hydrochloride on temporomandibular joint disorders: a pilot study. Cranio. 2001;19:130-9.
3. Leffler CT, Philippi AF, Leffler SG, Mosure JC, Kim PD. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil.Med. 1999;164:85-91.
4. Hughes R,.Carr A. A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. Rheumatology.(Oxford) 2002;41:279-84.
5. Rindone JP, Hiller D, Collacott E, Nordhaugen N, Arriola G. Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee. West J Med. 2000;172:91-4.
6. Muller-Fassbender H, Bach GL, Haase W, Rovati LC, Setnikar I. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis.Cartilage. 1994;2:61-9.
7. Bassleer C, Rovati L, Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro.Osteoarthritis.Cartilage. 1998;6:427-34.
8. Runkel DR,.Cupp MJ. Glucosamine sulfate use in osteoarthritis. Am.J Health Syst.Pharm. 1999;56:267-9.
9. Setnikar I, Palumbo R, Canali S, Zanolo G. Pharmacokinetics of glucosamine in man.Arzneimittelforschung. 1993;43:1109-13.
10. D’Ambrosio E, Casa B, Bompani R, Scali G, Scali M. Glucosamine sulphate: a controlled clinical investigation in arthrosis. Pharmatherapeutica 1981;2:504-8.
11. Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.Lancet 2001;357:251-6.
12. Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC. Glucosamine Sulfate Use and Delay of Progression of Knee Osteoarthritis: A 3-Year, Randomized, Placebo-Controlled, Double-blind Study. Arch.Intern.Med. 2002;162:2113-23.
13. Cibere J, Kopec JA, Thorne A, et al. Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis.Arthritis Rheum. 2004 Oct 15;51(5):738-45
14. Monauni T, et al. Effects of glucosamine infusion on insulin secretion and insulin action in humans.Diabetes. 2000;49(6):926-35.
15. Scroggie DA, Albright A, Harris MD. The effect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Arch Intern Med. 2003 14;163(13):1587-90.
16. Reichenbach S, Sterchi R, Scherer M, et al. Meta-analysis: Chondroitin for osteoarthritis of the Knee or Hip. Ann Intern Med. 2007 146:580-590.
17. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006 Feb 23;354(8):795-808.
18. Herro-Beaumont G, Ivorra JA, Del Carmen Trabado M, et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007 Feb;56(2):555-67.
19. Sawitzke AD, Shi H, Finco MF, et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: A report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum 2008 Sep 29;58(10):3183-3191.
20. Knudsen JF, Sokol GH. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database. Pharmacotherapy. 2008 Apr;28(4):540-8.
21. Lin PC, Jones SO, McGlasson DL. Effects of glucosamine and Celadrin on platelet function. Clin Lab Sci. 2010 Winter;23(1):32-6.
22. Wilkens P, Scheel IB, Grundnes O, et al. Effect of Glucosamine on Pain-Related Disability in Patients With Chronic Low Back Pain and Degenerative Lumbar Osteoarthritis. A Randomized Controlled Trial.JAMA. 2010;304(1):45-52.
23. Wandel S, Juni P, Tendal B, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010 Sep 16;341:c4675.
24. Ali AA, Lewis SM, Badgley HL, Allaben WT, Leakey JE. Oral glucosamine increases expression of transforming growth factor beta 1 (TGF-beta 1) and connective tissue growth factor (CTGF) mRNA in rat cartilage and kidney: implications for human efficacy and toxicity. Arch Biochem Biophys. 2011 Jun 1;510(1):11-8.